Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation | |
|---|---|---|
| D012868 | Skin Abnormalities NIH | 1.00 |
| D003876 | Dermatitis, Atopic NIH | 0.58 |
| D004485 | Eczema NIH | 0.58 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0000951 | Abnormality of the skin HPO | 0.71 |
| HP:0000964 | Eczema HPO | 0.58 |
| HP:0001047 | Atopic dermatitis HPO | 0.58 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0011123 | Inflammatory abnormality of the skin HPO | 0.50 |
Navigate: Correlations HPO
There is one clinical trial.
Hand washing and the use of hand sanitizers are important interventions in disease prevention. Engaging in frequent hand washing is especially effective in preventing the spread of viruses, as this removes microbes and prevents the spread to others. Hand dermatitis, however, is a common occurrence in certain occupations, such as healthcare workers. With the onset of the SARS-CoV2 (COVID-19) pandemic, hand hygiene measures are further enforced as there is no cure or vaccine for this virus. In the study, the effects of hand washing and the use of hand sanitizer on skin proteins and lipids will be assessed.
Description: Skin barrier assessments at baseline, then after hand sanitizer use will be performed. Analysis of skin filaggrin breakdown products, lipid profiles, and transepidermal water loss will be compared.
Measure: Measure the change in transepidermal water loss and skin components after using hand sanitizer. Time: Through study completion, up to 1 yearDescription: Skin barrier assessments after hand washing with soap and water will be performed. Analysis of skin filaggrin breakdown products, lipid profiles, and transepidermal water loss will be compared.
Measure: Measure the change in transepidermal water loss and skin components after hand washing with soap and water. Time: Through study completion, up to 1 yearDescription: Questionnaires will capture symptoms of hand dryness, frequency of hand washing, and other environmental exposures. This data will be compared to the degree of transepidermal water loss and skin barrier findings.
Measure: Individual reporting of hand dryness and environmental exposures Time: Through study completion, up to 1 yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports